Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
or

Nkgen Biotech Inc (NKGN)

Nkgen Biotech Inc (NKGN)
0.1225 +0.0106 (+9.47%) 15:52 ET [OTC US]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Quote Overview for Wed, Apr 23rd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.1200
Day High
0.1584
Open 0.1584
Previous Close 0.1119 0.1119
Volume 19,856 19,856
Avg Vol 123,463 123,463
Stochastic %K 27.67% 27.67%
Weighted Alpha -70.62 -70.62
5-Day Change -0.0077 (-5.91%) -0.0077 (-5.91%)
52-Week Range 0.0983 - 2.1900 0.0983 - 2.1900
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K 5,030
  • Shares Outstanding, K 44,948
  • Annual Sales, $ 0 K
  • Annual Income, $ -82,940 K
  • EBIT $ -41 M
  • EBITDA $ -40 M
  • 60-Month Beta 0.83
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.45
  • Most Recent Earnings $0.15 on 03/04/25
  • Next Earnings Date 05/19/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0983 +24.62%
on 04/09/25
Period Open: 0.1552
0.2089 -41.36%
on 03/31/25
-0.0327 (-21.07%)
since 03/21/25
3-Month
0.0983 +24.62%
on 04/09/25
Period Open: 0.5201
0.9100 -86.54%
on 02/12/25
-0.3976 (-76.45%)
since 01/23/25
52-Week
0.0983 +24.62%
on 04/09/25
Period Open: 1.8500
2.1900 -94.41%
on 05/23/24
-1.7275 (-93.38%)
since 04/23/24

Most Recent Stories

More News
NKGen Biotech To Present on the Use of Troculeucel for Alzheimer’s and Parkinson’s Disease at the 7th China International Biotechnology Conference & Exhibition

NKGN : 0.1225 (+9.47%)
NKGen Biotech Presents Data from Phase 1/2a Clinical Trial of Troculeucel in Moderate Alzheimer’s Disease at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™ 2025)

NKGN : 0.1225 (+9.47%)
NKGen Biotech To Present Updated Troculeucel Data at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™ 2025)

NKGN : 0.1225 (+9.47%)
NKGen Biotech To Present on Potential of Troculeucel for the Treatment of Neurodegenerative Diseases at the 13th Annual Alzheimer’s & Parkinson’s Drug Development Summit

NKGN : 0.1225 (+9.47%)
NKGen Biotech, Inc. to Transition from the Nasdaq Global Market to OTC Markets; Reverse Stock Split will not be Implemented

NKGN : 0.1225 (+9.47%)
NKGen Biotech Announces Administration of First Dose of Troculeucel to Stroke Patient Under FDA-Cleared Compassionate Use Program

NKGN : 0.1225 (+9.47%)
NKGen Biotech Announces Administration of First Dose of Troculeucel to Frontotemporal Dementia Patient Under FDA-Cleared Compassionate Use Program

NKGN : 0.1225 (+9.47%)
NKGen Appoints Dr. Anita Fletcher as National Principal Investigator for Phase 2a Troculeucel Trial Evaluating Moderate Alzheimer’s Disease with AdventHealth Orlando as First East Coast Site

NKGN : 0.1225 (+9.47%)
NKGen Biotech Announces Publication of Phase 1 Troculeucel Clinical Trial Results for the Treatment of Alzheimer’s Disease

NKGN : 0.1225 (+9.47%)
NKGen Biotech Receives U.S. FDA Fast Track Designation for Troculeucel for the Treatment of Moderate Alzheimer’s Disease

NKGN : 0.1225 (+9.47%)

Business Summary

NKGen Biotech Inc. is a clinical-stage biotechnology company. It focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies. NKGen Biotech Inc., formerly known as Graf Acquisition Corp. IV, is based in THE WOODLANDS, Texas.

See More

Key Turning Points

3rd Resistance Point 0.1897
2nd Resistance Point 0.1742
1st Resistance Point 0.1430
Last Price 0.1225
1st Support Level 0.0963
2nd Support Level 0.0808
3rd Support Level 0.0496

See More

52-Week High 2.1900
Fibonacci 61.8% 1.3910
Fibonacci 50% 1.1442
Fibonacci 38.2% 0.8973
Last Price 0.1225
52-Week Low 0.0983

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective